Dr. Martin is a distinguished scientist and engineer and published author whose groundbreaking work on COVID-19 and other pathogens has earned him a Nobel Prize nomination. His work on COVID and other Infectious Diseases Control has elevated him to the premier global authority in the realm of Infection and Disease Control technologies. With a career spanning over three decades and more than 2,000 projects, he has gained a reputation as the most knowledgeable global consultant and expert in the selection of the most efficient and effective technologies tailored to specific structures and applications.

Dr. Martin has lent his expertise to over 20 countries including various governments, and private entities. Having previously held membership in ASHRAE, Dr. Martin boasts a remarkable track record, with his past projects earning him prestigious 1st place awards in categories such as Existing Health Care and Existing Institutional Buildings. One of his notable projects was hailed as the Most Efficient Building in the Nation. In his role as the Environmental Consultant to The Faisal Group of Companies in Riyadh, Kingdom of Saudi Arabia, he has played a pivotal role in addressing environmental challenges. Moreover, Dr. Martin serves as a valued member of the W.H.O. Stop TB board, a dedicated researcher at the Infectious Diseases International Research Initiative in Ankara, Turkey, and a collaborative researcher with Camarines Norte State University in Daet, Philippines.

Included in his extensive international involvement, Dr. Martin has held the esteemed position of Chief Scientist at a biotechnology company in Tianjin, China, and is affiliated with a global engineering firm based in Dubai, UAE. His remarkable contributions have not gone unnoticed, as he was previously nominated for the W.H.O Kochon Prize in recognition of his innovative work on Tuberculosis within buildings, which has significantly reduced treatment times and enhanced the efficiency of treating infected individuals.

In 2021, Dr. Martin’s groundbreaking work on Infection Control, including COVID-19, garnered that Nobel Prize nomination. The nomination highlighted his ingenuity and dedication to addressing pressing global health challenges. His innovative solutions are specifically designed to target pathogenic bioaerosols and VOCs, mitigating their impact and preventing them from becoming respirable, thus contributing to a safer and healthier world and reducing potential litigation issues.